Transient Receptor Potential Cation Channel Subfamily V Member 1 Pipeline...
Transient Receptor Potential Cation Channel Subfamily V Member 1 Pipeline Review H2 2019SummaryTransient Receptor Potential Cation Channel Subfamily V Member 1 Capsaicin Receptor or Vanilloid Receptor...
View ArticleEarly Deep Remission of Crohn Disease Tied to Better Outcomes
FRIDAY April 3 2020 Deep early remission of Crohn disease is associated with a significant decrease in longterm adverse effects according to a study published online March 26 in Gastroenterology.Ryan...
View ArticleInterleukin 1 Receptor Type 1 Pipeline Review H2 2019 Published by Global...
Interleukin 1 Receptor Type 1 Pipeline Review H2 2019SummaryInterleukin 1 Receptor Type 1 CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1 Interleukin 1...
View ArticleStageZero Life Sciences Announces Publication of Abstract at American Society...
StageZero Life Sciences Announces Publication of Abstract at American Society of Clinical OncologyTORONTO ON ACCESSWIRE April 3 2020 StageZero Life Sciences Ltd TSXSZLS "StageZero" or...
View ArticleFormaldehyde Dehydrogenase Pipeline Review H2 2019 Published by Global...
Formaldehyde Dehydrogenase Pipeline Review H2 2019SummaryAccording to the recently published report 'Formaldehyde Dehydrogenase Pipeline Review H2 2019'; Formaldehyde Dehydrogenase S Nitrosoglutathione...
View ArticleAnalysis on Impact of Covid19 Global Antiinflammatory Therapeutics Market...
The global antiinflammatory therapeutics market is poised to grow by USD 27.53 billion during 20202024 progressing at a CAGR of over 6 during the forecast period. Request free sample pagesThis press...
View ArticleCrohn's Disease CD Market Review Epidemiology And Market Forecast 2029...
FirstView Market Insight " Crohn's Disease Market Review Epidemiology and Market Forecast 2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed market...
View ArticleCrohn's diseasePricing Market Access and Landscape 2019 Published by First...
Firstview Insight's Crohn's diseasePricing Market Access and Landscape 2019 provides country specific insights in order to estimate market potential for Crohn's disease based on the pricing and...
View ArticleSphingosine 1Phosphate Receptor 1 Pipeline Review H2 2019 Published by Global...
Sphingosine 1Phosphate Receptor 1 Pipeline Review H2 2019SummarySphingosine 1Phosphate Receptor 1 Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or...
View ArticleReceptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019 Published by...
Receptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019SummaryAccording to the recently published report 'Receptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019'; Receptor Tyrosine...
View ArticleAlpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter...
Completion of Phase 1 Study for Lead AutoimmuneInflammatory Disease Program ALPN101BALANCE Trial of ALPN101 in Acute GVHD Open for EnrollmentNEON1 Trial of ALPN202 in Advanced Malignancies Open for...
View ArticleProtein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2019 Published...
Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2019SummaryProtein Phosphatase 2A PP2A or EC 3.1.3.16 pipeline Target constitutes close to 7 molecules. Out of which approximately 5...
View ArticleBristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of...
Bristol Myers Squibb NYSEBMY today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency has adopted a positive opinion for ZEPOSIAÂ ozanimod for the...
View ArticleMechanisms to prevent Crohn's disease unveiled
In a series of four studies published today inflammatory bowel disease IBD researchers describe the identification of predictive tools and a new understanding of environmental factors that trigger IBD.
View ArticlePatients and RWE Is this the year
The longhyped redefinition of healthcare through wearable tech has been well long hyped. Early projects such as Apple HealthKit and Fitbit were undoubtably important in redefining the possible but they...
View ArticleU.S. Food and Drug Administration Approves Bristol Myers Squibbs ZEPOSIAÂ...
In clinical trials ZEPOSIA demonstrated efficacy on a key clinical marker of disease activity annualized relapse rate ARR as compared to AVONEXÂ interferon beta1a123ZEPOSIA is a sphingosine1phosphate...
View ArticleFDA approves ozanimod a drug invented at Scripps Research for multiple sclerosis
Scripps Research Institute The US Food and Drug Administration has approved ozanimod an immunemodulating therapy invented at Scripps Research for the treatment of adults with relapsing forms of...
View ArticleMount Sinai researchers unveil mechanisms to prevent Crohn's disease
The Mount Sinai Hospital Mount Sinai School of Medicine In a series of four studies published today in Gastroenterology a journal of the American Gastroenterological Association Mount Sinai...
View Article
![[-100%] Commodity Intelligence – (Android Apps)](http://play-lh.googleusercontent.com/j67-qJvmnn4xnVlYVZ9ZhtZUJIgwjKekJGoKQT6D1KHcWGZxtQaFroummEvwV17na7tyh1pGbbeWCRdWtTKqeg=w950-h950)
